Medical/Pharmaceuticals
ArkBio Announces Successful Completion of Enrollment and Dosing for Phase 1 Clinical Study of AK0610, a Preventive Antibody Against Respiratory Syncytial Virus Infection
SHANGHAI, Nov. 25, 2024 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") announced today the successful enrollment and dosing of all participants in a Phase 1 clinical study of AK0610, a fully human monoclonal antibody designed to prevent respiratory syncytial virus (RSV) infec...
2024-11-25 08:18
1873
SCG Cell Therapy Presents Promising Phase 1 Data for a Novel HBV-Specific TCR-T Therapy (SCG101) at the AASLD Liver Meeting 2024
SINGAPORE, Nov. 25, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers, announced late-breaking data from its Phase 1 trial of SCG101, a first-in-class autolog...
2024-11-25 08:01
1310
Hankyung.com introduces: MecKare, Leading the AI-powered Innovation in Health Monitoring Solution
- Leading efficient care management for the elderly with unimpeded smartcare
https://img.hankyung.com/pdsdata/pr.hankyung.com/uploads/2024/11/image01-1.png
2024-11-23 21:00
2988
Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs
* Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in their lifetime1 * Previous studies have shown that VETMEDIN® could help improve the survival time and quality of life for dogs with congestive heart failure due to myxomatous mitral v...
2024-11-23 05:09
2224
International Genomics Conference (ICG-19) Opens at BGI Group HQ in Shenzhen
SHENZHEN, China, Nov. 22, 2024 /PRNewswire/ -- The 19th Annual Meeting of the International Conference on Genomics (ICG-19) officially opened at BGI Group's Global Headquarters inShenzhen. This annual event brings together over 100 leaders in the field of genomics from the U.S., UK,Denmark, Austr...
2024-11-22 21:57
3883
BGM Group Welcomes Guilin Pharma for On-site Audit and Partnership Development
CHENGDU, China, Nov. 22, 2024 /PRNewswire/ -- On November 19, Qilianshan Pharmaceutical Co., Ltd. (Qilian Pharma), a subsidiary of BGM Group Ltd, welcomed a team of experts from Guilin Pharmaceutical Co., Ltd. (Guilin Pharma), including Quality Assurance Engineer Ms. Shen and Technical Manager M...
2024-11-22 21:30
2164
Akeso's Penpulimab Combination Therapy for First-line Treatment of Hepatocellular Carcinoma Accepted by NMPA
HONG KONG, Nov. 22, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the National Medical Products Administration (NMPA) of China has accepted its supplemental new drug application (sNDA) for penpulimab, a differentiated PD-1 monoclonal antibody, in combination...
2024-11-22 19:34
1388
FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer
NANJING, China, Nov. 22, 2024 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs") announced that LBL-024, an anti-PD-L1/4-1BB bispecific antibody independently developed by the company with global intellectual property rights for the treatment of neuroendo...
2024-11-22 16:00
6674
Two In Vitro Studies on Eravacycline (XERAVA®) Presented at IDWeek, Demonstrating Its Sustained and Robust Antimicrobial Activity
SHANGHAI, Nov. 22, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that data on its critical-care, anti...
2024-11-22 12:14
2081
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology
ROCKVILLE, Md. and SUZHOU, China, Nov. 22, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, announced today that findings from a ph...
2024-11-22 10:27
1990
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology
ROCKVILLE, Md. and SUZHOU, China, Nov. 21, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, announced today that findings from a ph...
2024-11-22 10:15
1512
United Imaging Announces the First of Several New U.S. Product Launches For RSNA
The first uMI Panvivo in the world lands at the growing Pueblo Medical Imaging inNevada. HOUSTON, Nov. 21, 2024 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has installed the world's first uMI Panvivo PET/CT at Pueblo Medical Imaging inN...
2024-11-22 03:00
1103
TELUS Mental Health Index: Mental health of workers in Australia hits four-year low, costing businesses up to 69 workdays of productivity annually per employee
New data reveals younger workers and those without savings face the highest mental health risks, while strong employer support can halve productivity losses SYDNEY, Nov. 22, 2024 /PRNewswire/ -- Today, TELUS Health released its TELUS Mental Health Index ("the Index") with reports that examine the...
2024-11-22 02:00
1090
poLight ASA receives purchase order for TWedge® wobulator technical samples from a top tier consumer OEM customer
TØNSBERG, Norway, Nov. 22, 2024 /PRNewswire/ -- poLight ASA (OSE: PLT) today announced that the company has received a purchase order worth approximatelyNOK 500,000 to supply its TWedge® wobulator technical samples to a top tier consumer OEM customer for an AR/MR application. "Our customer inter...
2024-11-22 00:44
1534
TELUS Mental Health Index: Singapore's workforce faces growing mental health crisis, threatening productivity and physical health
New research reveals sharp declines in mental health scores reversing two years of modest but steady improvement SINGAPORE, Nov. 21, 2024 /PRNewswire/ -- Today, TELUS Health released its TELUS Mental Health Index (the "Index") with reports examining the mental health of employed people inSingapo...
2024-11-22 00:01
1206
TELUS Mental Health Index: 40 per cent of workers in New Zealand have high mental health risk as productivity losses mount
Workers diagnosed with anxiety lose more than 68 working days of productivity per year, underscoring the economic impact ofNew Zealand's declining mental health scores AUCKLAND, New Zealand, Nov. 22, 2024 /PRNewswire/ - Today, TELUS Health released itsTELUS Mental Health Index ("the Index") with...
2024-11-22 00:00
1081
The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development
LONDON, Nov. 21, 2024 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of itsGenScript Biotech Global Forum in London, UK. Since its inaugural session at the J.P. Morgan Healthcare Conference inS...
2024-11-21 23:46
1279
I-Mab to Participate at the Piper Sandler Healthcare Conference
The 36th Annual Healthcare Conference will be held in New York, December 3-5, 2024 ROCKVILLE, Md., Nov. 21, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB, the "Company"), a U.S.-based global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treat...
2024-11-21 20:00
1184
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
Launch of new application enables global access to highly recognized solid tumor profiling assay BOSTON and ROLLE, Switzerland, Nov. 21, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, announced the global launch of MSK-IM...
2024-11-21 18:30
1304
3Shape A/S and Medit Corp. Reach Settlement in Patent Infringement Lawsuit
COPENHAGEN, Denmark, Nov. 21, 2024 /PRNewswire/ -- 3Shape A/S, a global innovator in digital dentistry with its market-leading intraoral (IOS) scanners, and Medit Corp, a leading provider of dental 3D scanners, today announced they have settled U.S. patent infringement litigation. Both companies...
2024-11-21 18:18
1294
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 337 media titles]
2025-01-18 03:30
Supported by the Luxembourg Government, The Luxembourg House of Financial Technology (LHoFT) and the Asian Development Bank (ADB) Announce the 2nd Edition of Catapult | SE Asia 2025
[Picked up by 313 media titles]
2025-01-22 15:38
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 311 media titles]
2025-01-18 17:00
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
[Picked up by 309 media titles]
2025-01-21 16:00
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 306 media titles]
2025-01-20 14:27
Most Read
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
2025-01-18 03:30
12427
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
2025-01-18 17:00
11626
EZGO ANNOUNCES FINANCIAL RESULTS FOR FISCAL YEAR 2024
2025-01-18 06:45
8786
MONTECH Debuts the Heritage: A New Era of Leather Craft & High-End PC
2025-01-18 22:00
5500
